DRAFT Biological Containment Isolation System (BCIS)

SOL #: W911QY-26-S-BCIS-01Pre-Solicitation

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W6QK ACC-APG NATICK
NATICK, MA, 01760-5011, United States

Place of Performance

Place of performance not available

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

Safety And Rescue Equipment (4240)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 17, 2026
2
Last Updated
Apr 9, 2026
3
Response Deadline
Apr 1, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), Natick Division, has issued a Draft Call for Solutions (CFS) for a Biological Containment Isolation System (BCIS) prototype. This effort, under the Army Open Solicitation (AOS) W9128Z-25-S-A002 and 10 U.S.C. § 4022 Other Transaction Authority (OTA), seeks innovative solutions for managing High-Consequence Infectious Disease (HCID) patients in austere environments. Solution Briefs are anticipated to be due by mid-May 2026.

Purpose & Scope

The primary goal is to develop a deployable, negative pressure Multi-Patient BCIS tent/shelter, preferably by adapting existing DoD tents like the USAF UTS TMT60. The system must rapidly isolate and treat infected individuals, manage disease control, and reduce transmission risks. Key performance thresholds include 0.01 In.w.g. negative pressure, 12 Air Changes per Hour (ACH), and 99.97% filtration efficiency for 0.3-micron particles. The system must be Berry Amendment compliant, reusable, and capable of accommodating at least five patients. Monitors for pressure loss are required.

Contract Details & Phased Approach

This is a multi-phase prototype project. Up to three (3) Prototype OTAs will be awarded for Phase I (TRL 6, delivery within 60-90 days), with a down-selection to up to two (2) contractors for Phase II (TRL 7). Successful completion may lead to a non-competitive follow-on production contract for up to 15 units. Cost will be a factor in the evaluation for the production phase. The Government strongly prefers Unlimited Rights for all technical data, software, and IP, with Government Purpose Rights (GPR) as the minimum acceptable.

Eligibility & Evaluation

This opportunity emphasizes significant participation from non-traditional defense contractors and/or small businesses, a foundational element of the acquisition strategy. Partnering is preferred. The submission process is two-step:

  1. Solution Brief: Max 15 pages, plus Supporting Data Package.
  2. Request for Solution Proposal (RSP): For invited offerors. Evaluation criteria for Solution Briefs include Technical Merit, Innovation & IP, and Non-Traditional/Small Business Participation.

Key Dates & Contacts

People

Points of Contact

Andrew R. RhodesSECONDARY

Files

Files

Download
Download
Download
Download
Download
Download

Versions

Version 3Viewing
Pre-Solicitation
Posted: Apr 9, 2026
Version 2
Pre-Solicitation
Posted: Mar 17, 2026
View
Version 1
Pre-Solicitation
Posted: Mar 17, 2026
View
DRAFT Biological Containment Isolation System (BCIS) | GovScope